In recent trading session, Carisma Therapeutics Inc (NASDAQ:CARM) saw 0.56 million shares changing hands at last check today with its beta currently measuring 1.54. Company’s recent per share price level of $1.01 trading at -$0.02 or -1.94% at last check today assigns it a market valuation of $41.96M. That most recent trading price of CARM’s stock is at a discount of -224.75% from its 52-week high price of $3.28 and is indicating a premium of 20.79% from its 52-week low price of $0.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.17 million shares which gives us an average trading volume of 136.52K if we extend that period to 3-months.
For Carisma Therapeutics Inc (CARM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Carisma Therapeutics Inc (NASDAQ:CARM) trade information
Upright in the red during last session for losing -1.94%, in the last five days CARM remained trading in the green while hitting it’s week-highest on Wednesday, 11/06/24 when the stock touched $1.01 price level, adding 10.62% to its value on the day. Carisma Therapeutics Inc’s shares saw a change of -65.53% in year-to-date performance and have moved 1.00% in past 5-day. Carisma Therapeutics Inc (NASDAQ:CARM) showed a performance of 8.25% in past 30-days. Number of shares sold short was 1.05 million shares which calculate 10.74 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 83.17% to its recent value today. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -494.06% in reaching the projected high whereas dropping to the targeted low would mean a loss of -494.06% for stock’s current value.
Carisma Therapeutics Inc (CARM) estimates and forecasts
Statistics highlight that Carisma Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -31.76% of value to its shares in past 6 months, showing an annual growth rate of 48.65% while that of industry is 18.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 24.98% during past 5 years.
Carisma Therapeutics Inc (NASDAQ:CARM)’s Major holders
Insiders are in possession of 28.68% of company’s total shares while institution are holding 33.82 percent of that, with stock having share float percentage of 47.42%. Investors also watch the number of corporate investors in a company very closely, which is 33.82% institutions for Carisma Therapeutics Inc that are currently holding shares of the company.
